Moderna will invest $140 million in expanding its U.S. manufacturing capacity and onshoring its drug manufacturing to its existing facility in Norwood, Mass. The company said it will now operate full ...

Pharmaceutical giant Merck announced the cancellation of a planned $1.3 billion research center in London and the termination ...

Eleva’s CEO says CHO cell line alternatives could become common in therapeutic protein manufacturing, as large molecule drugs become complex and harder to produce at scale.

Now, more than half a year later, the expansion plan for one of the company’s new facilities—a former magazine plant in ...

The agreement as a strategic milestone in Egypt’s efforts to localize pharmaceutical manufacturing and introduce advanced ...

Lucknow: Uttar Pradesh govt is set to establish a strong footprint in the pharmaceutical sector, with major projects ...

The document, from the US-China Economic and Security Review Commission, warns that if China did choose to restrict access to ...

· In return for their investment in U.S. manufacturing, the administration would drop a proposed 100% tariffs on branded and patented drugs imported to the U.S. · Trump’s push for most-favored-nation ...

Regeneron is expanding its pharmaceutical production in New York, joining a wave of drug companies growing domestic ...

PwdRx novel drug delivery platform demonstrated superior bioavailability and accelerated absorption of cannabinoids in ...

Amanda Murphy, Senior Director at GlobalData, discusses how real-time intelligence can turns regulatory events into opportunities.

Indian generics would soon become the backbone of the global HIV response. Within two years, the US launched PEPFAR, the ...